Loading

JSM Sexual Medicine

Sexually Transmitted Infections and Emergency Contraception in University Students in Majorca, Spain

Research Article | Open Access | Volume 6 | Issue 2

  • 1. Department of Nursing and Physiotherapy, University of Balearic Islands (UIB), Spai
  • 2. Balearic Islands Health Research Institute (IdISBa), Palma, Spain
  • 3. APLICA, Madrid, Spain
  • 4. Son Ferriol Health Center, Majorca Department of Primary Care, Ibsalut, Palma, Spain
  • 5. Research Unit, Majorca Department of Primary Care, Ibsalut, Palma, Spain
  • 6. Preventive Activities and Health Promotion Research Network, (RedIAPP), Spain
+ Show More - Show Less
Corresponding Authors
Maria de Lluc Bauzà-Amengual, Department of Nursing and Physiotherapy, University of Balearic Islands (UIB), Spain, Email: mlluc.bauza@uib.es
Abstract

The aim is to analyze emergency contraception (EC) use and sexually transmitted infections (STIs) among university students (UE). It is a cross-sectional descriptive study conducted at the University of Balearic Islands. Female and male UE were invited to complete a self-administered questionnaire. The dependent variable was the presence of an STI. The independent variables were sociodemographic characteristics, drug use, sexual behavior and use of EC. We recruited 1588 students. The median age was 20; 807 (67%) were women; and 51 UE reported an STI in the last 12 months (3.9%, 95%CI, 2.9-4.4): chlamydia (13.7%), genital herpes (13.7%) and candidiasis (54.9%). The variables associated with STIs were taking oral contraceptives (OR=0.37, 95%CI, 0.19-0.74), first sexual experience before the age of 16 (OR=1.94, 95%CI, 1.08-3.50), having had 3-5 sexual partners (OR=2.27, 95%CI, 1.04-4.90), 6-9 (OR=2.79, 95%CI, 1.56-9.22) or ≥10 (OR=4.59, 95%CI, 1.98-10.68), and irregular use of condoms OR=3.62, 95%CI, 1.53-8.57). In the adjusted model, having an STI in the previous 12 months was related to age (OR=0.87, 95%CI, 0.79-0.96), female sex (OR=7.02, 95%CI, 2.52-19.53), irregular condom use (OR=4.60 95%CI, 0.10-0.51), having 3-5 (OR=2.47, 95%CI, 1.04-5.85)¸ 6-9 (OR=3.98, 95%CI, 1.45-10.89), or ≥10 (OR=5.77, 95%CI, 1.99-16.67) sexual partners, and illegal drug use (OR=2.25, 95%CI,1.05-4.79). EC use and oral contraception exerted a protective effect against STIs. EC users had less risk of acquiring an STI, and EC use in our study seemed to have a protective effect against STIs. Our findings suggest that UE may engage in less risky sexual health behaviors than their non-university peers and that there may be a tendency towards overprotection in this setting.

Keywords

Sexually transmitted diseases; Post-coital contraception; Unsafe sex; risk factors; Students

Citation

de Lluc Bauzà-Amengual M, March S, Esteva A, Miralles-Xamena J, Esteva M (2022) Sexually Transmitted Infections and Emergency Contraception in University Students in Majorca, Spain. JSM Sexual Med 6(2): 1086.

INTRODUCTION

Developed countries have made considerable efforts in recent years to facilitate access to emergency contraception (EC) as a means of reducing unintended pregnancy and abortion [1]. EC is currently used by over 100 million women worldwide and this number is on the rise. In the USA, the percentage of EC users increased from 4% in 2006 to 10% in 2008 [2]. In Spain, 30% of women of childbearing age and 38% of those aged between 25 and 34 years report having used EC at some time in their life [3].

Various studies have shown that EC users are typically single women in their 20s who use condoms as their main method of contraception [4,5]. The most common reasons cited for EC use are a broken condom, unprotected sex, and a missed contraceptive [6,7].

On September 28, 2009, the Spanish government approved over-the-counter access to EC in pharmacies, sparking a debate on whether this would result in higher-risk sexual behavior and, consequently, an increase in sexually transmitted infections (STIs) [8,9]. A number of European and US studies have shown that compared with non-users, EC users have more sexual partners [10,11], start sexual intercourse at an earlier age [2,5], use condoms more frequently [10], and are more inconsistent in their use of condoms and other contraceptive methods [11]. EC use has also been linked to alcohol and other drugs [12].

STI risk has been associated with various sexual behaviors and risk factors, such as inadequate sexual health information, frequent unprotected sex with different partners, use of psychoactive substances, and sexual debut before the age of 16 [9]. STIs also tend to be more common in young, single people living in urban areas. Although adolescents and young adults (15- 24 years) comprise 25% of the sexually active population, they account for almost 50% of those who acquire an STI[9].

STIs have become a major public health challenge worldwide, as they place a considerable economic strain on healthcare systems and cause significant morbidity and mortality [13,14]. There has been an increasing trend in STI diagnosis in Spain since the early 2000s, and with the exception of chlamydia, men are infected more often than women [13]. The most common STIs are chlamydia, genital herpes, human papillomavirus infection, syphilis, HIV infection, candidiasis, scabies, and crab louse (caused by Pthirus pubis)[15].

Both healthcare providers and EC users are therefore concerned that easier access to EC might increase risky sexual behaviors and STIs.

The most recent information available on sexuality and sexual health in the general Spanish population is from the 2019 National Sexual Health Survey [16]. Few studies thus far have analyzed the relationship between STIs and EC use in Spain. A better understanding of this relationship is essential for informing effective preventive interventions [17]. The aim of this study was to analyze EC use and STIs in a population of university students in Majorca, Spain. This aim is in line with the 2030 Agenda and its 17 Sustainable Development Goals (SDGs) from the United Nations, approved by the Spanish Government on September 25, 2015. Concretely, with the goals related to decreasing transmissible diseases and integrating sexual health in national strategies and programs [18].

MATERIAL AND METHODS

Design, Population, and Sample

This was a cross-sectional descriptive study in which male and female university students from the University of the Balearic Islands (UIB) in Palma de Mallorca, Spain completed a self-administered questionnaire. Only students who had engaged in vaginal intercourse were included in our analysis. We included both male and female students as, even though EC is used by women, we consider that both men and women should take responsibility for their sexual and reproductive health. The full description of the study methodology is available elsewhere [12].

Data Collection

The study questionnaire was developed ad hoc following a review of the literature. It was piloted among 50 nursing students who checked its comprehensibility, rated the adequacy of the different items, and estimated the time required for completion. The questionnaire was then modified before being distributed to the study population, recruited from the largest degree courses at the UIB. The tutors responsible for these courses were contacted to request their collaboration and to schedule the administration of the questionnaire. The self-administered, anonymous and voluntary questionnaire was distributed by a field researcher in the selected classrooms in 2016.

Definition of Variables

The dependent variable was the presence of an STI, assessed by the question “Have you had an STI in the last 12 months”? [19] a proxy for STI diagnosis, we assessed use of sexual healthcare services in the same period, as reported by Habel et al., [2]. This was assessed by the question “Have you received STI counseling, testing, or treatment in the last 12 months?”. The students were also asked to specify the type of STI. The main variable was use of EC in the last 12 months (“Have you or your sexual partner used EC in the last 12 months”?), and frequency of EC use. The independent variables were sociodemographic characteristics (gender, age, marital status, country of birth, place of residence [city of Palma of Majorca vs. elsewhere on the island], cohabitants, parents’ level of education and current job situation), and current smoking, alcohol consumption and illegal drug use. We also asked whether they had ever used specific illegal drugs (cannabis, cocaine, ecstasy, ketamine, and heroine); as well as details about their sexual behavior (age at first sexual intercourse, frequency of intercourse, number of lifetime sexual partners, frequency of intercourse without a condom, use of contraception during the last three sexual encounters, and usual type of contraception).

Statistical Analysis

A descriptive analysis was performed for all variables. We calculated percentages for categorical variables and mean and standard deviations for quantitative variables. Bivariate analysis for the presence of an STI in the last 12 months as the dependent variable was also performed. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Significant factors in the bivariate analysis and other variables deemed relevant (age, marital status, country of origin, alcohol consumption, use of condom as a contraceptive, age at first sexual intercourse, frequency of sexual intercourse, use of contraceptive in the last three sexual encounters) were included in a multivariate logistic regression model to identify independent predictors for the presence of an STI in the last year with the backward LR method. Variations of the model were compared using maximum likelihood estimation, with elimination of variables that did not have a significant impact on outcome and testing of all interactions. We evaluated goodness of fit of the model with the Hosmer Lemeshow test and the receiver operating characteristic. The collinearity of variables was assessed through calculation of variance inflation factor (VIF) values. Analyses were performed in IBM SPSS (version 23).

Ethical considerations

The study was approved by the Balearic Islands Research Ethics Committee (IB-790/14) and the research committee of the UIB. The study was performed in accordance with the principles of the Declaration of Helsinki. Participation was voluntary and anonymity was maintained at all times. Participation or nonparticipation did not have any academic or other repercussions for students.

RESULTS

The study questionnaire was completed by 1588 students. Just one of the students approached refused to participate. In total, 1309 students (82.0%) reported having engaged in sexual intercourse at some time in their life, and of these, 58 (4.4%) did not answer the question on the presence of an STI in the last 12 months. We therefore analyzed responses from 1251 students. The sociodemographic characteristics of the group overall and stratified by reported presence/absence of an STI in the last 12 months are shown in Table 1. The median age of the students was 20 (IQR, 17-53 years), and 95% were younger than 32. Sixty-seven percent were women, approximately one-third had a partner, and 76% lived with their parents/guardians. One in ten students had been born outside Spain and nearly half was living in Palma de Majorca. In total, 54.7% of mothers and 48.1% of fathers had a high school education.

Table 1. Student characteristics overall and according to STI diagnosis.
Variable

TOTAL

N (%)

STI

n (%)

NON-STI

n (%)

OR (95% CI) P*
  N = 1251 N = 51 N = 1200    
Age: median (SD) 20 (5.4) 21.6 (3.8) 22.3 (5.4) 0.97 (0.91-1.03) .22

Sex

Male

Female

393 (32.8)

807 (67.3)

7 (1.8)

45 (5.2)

393 (98.2)

989 (94.8)

1

3.06 (1.36-6.85)

<0.01

Marital status

In a partnership

Single/separated/

divorced/widow

458 (37.5)

802 (62.5)

 

 

21 (3.9)

30 (4.6)

 

 

437 (96.1)

733 (95.4)

 

 

1

0.85 (0.48-1.50)

 

0.58

Living with

Parents/guardian

Other

936 (75.7)

301 (24.3)

36 (3.8)

15 (5.0)

900 (96.2)

286 (95.0)

1

1.31 (0.78-2.43)

0.38

Country of birth

Spain

Other

1134 (90.9)

113 (9.1)

44 (3.8)

7 (6.1)

1090 (96.2)

106 (93.9)

1

1.63 (0.71-3.72)

0.23

Residence

Palma

Other

547 (44.2)

691 (55.8)

22 (4.0)

29 (4.2)

525 (96.0) 662 (95.8)

1

1.04- (0.59-1.84)

0.87

Mother’s level of education No studies/primary Secondary

University

211 (17.0) 680 (54.7) 353 (28.4) 8 (3.8) 26 (3.8) 17 (4.8) 203 (96.2) 654 (96.2) 336 (95.2)

1

1.10 (0.43-2.82)

1.32(0.47-3.71)

0.72

Father’s level of education No s

tudies/primary

Secondary

University

259 (20.9)

596 (48.1) 383 (30.9)

11 (4.2) 596 (3.7) 383 (4.7) 248 (95.8) 574 (96.3) 365 (95.3)

1

0.81 (0.34-1.89)

0.97 (0.38-2.44)

0.73

CI, confidence interval; EC, emergency contraception; OR, odds ratio; STI, sexually transmitted infection. *Chi square test

 

Fifty-one students (3.9%, 95% CI 2.9-4.4) reported an STI in the last 12 months. Reported STI rates were significantly higher in female students. No differences were observed for the other sociodemographic variables. Over one-fifth of students (n=267, 21.3%) reported having received STI counseling, testing, or treatment in the last 12 months. The most common STIs mentioned in those who reported any STI were chlamydia (13.7%), genital herpes (13.7%) and candidiasis (54.9%).

Table 2 shows the self-reported STI by EC use and sexual/ lifestyle habits. There was no significant difference in reported STI rates between students who had never used EC and those who had used EC once or more. STI rates were significantly higher among students not taking oral contraceptive pills and those who had had their first sexual experience before the age of 16, those who had had 10 or more sexual partners, and those who did not use or only occasionally used condoms during sex. Students who reported an STI in the last 12 months were also more likely to have received STI counseling, testing, or treatment. Having an STI in the previous 12 months was not significantly associated with frequency of sexual intercourse or use of contraception in the last three sexual encounters. Finally, students who reported an STI were more likely to smoke and use illegal drugs, and have used cannabis, cocaine, ecstasy, and ketamine (only four students declared ever having used heroin). No significant difference was observed for alcohol use.

Table 2: EC use and sexual and lifestyle habits and according to self-reported STI.
Variable

TOTAL

n (%)

STI

n (%)

NON-STI

n (%)

OR (95% CI) P*
  N=1251 N=51 N= 12 00    

Type of contraception

Condom (yes)

Oral contraception (pill) (yes)

766 (61.2)

516 (41.2)

35 (4.6)

11 (2.1)

731 (95.4)

505 (97.9)

1.40 (0.76-2.56)

0.37 (0.19-0.74)

0.28

0.004

Ever used EC

No

Yes

738 (59.9)

495 (40.1)

28 (3.8)

21 (4.2)

710 (96.2)

474 (95.8)

1

1.12 (0.63-2.20)

0.69

Frequency of EC use

Once

≥ 2 times

280 (58.0)

203 (42.0)

9 (3.2)

11 (5.4)

70 (96.8)

192 (94.6)

1

1.72 (0.70-4.24)

0.23

Age at first sexual intercourse

≥16 years

<16 years

928 (75.1)

307 (24.9)

31 (3.5)

19 (6.5)

867 (96.5)

273 (93.5)

1

1.94 (1.08-3.50)

0.02

Frequency of sexual intercourse

Sporadic

≥1 per week

458 (37.4)

765 (62.6)

18 (3.9)

33 (4.3)

440 (96.1)

732 (95.7)

1

1.10 (0.61-1.98)

0.74

No. of sexual partners

1-2

3-5

6-9

≥10

584 (50.3)

330 (28.4)

122 (10.5)

125 (10.8)

12 (2.1)

15 (4.5)

9 (7.4)

11 (8.8)

572 (97.9)

315 (95.5)

113 (92.6)

114 (91.2)

1

2.27 (1.04-4.90)

2.79 (1.56-9.22)

4.59 (1.98-10.68)

0.003

Frequency of intercourse without a condom

Never

Always/most of the time/sometimes

409 (32.2)

833 (67.8)

6 (1.5)

44 (5.3)

390 (98.5)

789 (94.7)

1

3.62 (1.53-8.57)

0.002

Use of contraceptive in last 3 sexual encounters

Yes (all 3)

Never/not in all 3

813 (67.5)

419 (32.5)

29 (3.6)

21 (5.4)

784 (96.4)

370 (94.6)

1

1.53 (0.86-2.72)

0.14

Receipt of STI counseling, testing, or treatment in last 12 months?

No

Yes

965 (78.7)

261 (21.3)

7 (0.7)

40 (15.3)

958 (99.3)

221 (84.7)

1

24.77 (10.95-56.02)

<0.001

Current smoker

No

Yes

923 (79.2)

242 (20.8)

18 (7.4)

31 (3.3)

224 (92.6)

892 (96.7)

1

2.31 (1.27-4.20)

0.005

Alcohol use

Non-drinker/sporadic

Drinker

923 (74.6)

315 (25.4)

35 (3.8)

15 (4.8)

88 (96.2)

300 (95.2)

1

1.26 (0.68-2.35)

0.45

Cannabis (ever used)

No

Yes

768 (69.9)

330 (30.1)

25 (3.3)

22 (6.7)

743 (96.7)

308 (93.3)

1

2.12 (1.17-3.82)

0.01

Cocaine (ever used)

No

Yes

985 (83.1)

66 (16.9)

39 (4.0)

8 (12.1)

946 (96.0)

58 (87.9)

1

3.34 (1.49-7.48)

0.002

Ecstasy (ever used)

No

Yes

984 (94.8)

54 (5.2)

39 (4.0)

8 (14.8)

945 (96.0)

46 (85.2)

1

4.21 (1.86-9.53)

<0.001

Ketamine (ever used)

No

Yes

1012 (97.8)

23 (2.2)

40 (4.0)

4 (17.4)

972 (96.0)

19 (82.6)

1

5.11 (1.66-15.73)

0.002

Illegal drug (current use)

No

Yes

1020 (83.1)

207 (16.9)

32 (3.1)

18 (8.7)

988 (96.9)

107 (91.3)

1

2.94 (1.61-5.34)

<0.001

CI, confidence interval; EC, emergency contraception; OR, odds ratio; STI, sexually transmitted infection

*Chi square test

 

The results of the multivariate analysis are shown in Table 3. The variables associated with an increased likelihood of having had an STI in the last 12 months were age, female sex, and irregular condom use, number of sexual partners, smoking, and illegal drug use. EC use, oral contraception, and age (to the highest age) all exerted a protective effect against STI.

Table 3: Adjusted logistic regression model showing independent predictors of STI
Variable OR 95% CI P
Age (years) 0.87 0.79-0.96 0.008

Sex

Male

Female

 

1

7.02

 

 

2.52-19.53

 

 

<0.001

Marital Status

In a partnership

Single/separated/divorced/widow

 

1

1.52

 

 

0.77-3.02

 

 

0.22

EC use

No

Yes

 

1

0.39

 

 

0.19-0.79

 

 

0.01

Oral contraception use

No

Yes

 

1

0.23

 

 

0.10-0.51

 

 

<0.001

Frequency of intercourse without a condom

Never

Always/most of the time/sometimes

 

1

4.60

 

 

1.60-11.60

 

 

0.03

Number of sexual partners

1-2

3-5

6-9

≥10

 

1

2.47

3.98

5.77

 

 

1.04-5.85

1.45-10.89

1.99-16.67

 

 

0.04

0.007

0.001

Current Smoker

No

Yes

 

1

2.14

 

 

1.03-4.45

 

 

0.04

Illegal drug (current use)

No

Yes

 

1

2.25

 

 

1.05-4.79

 

 

0.03

ROC=0.83. Hosmer and Lemeshow goodness of fit= 0.52. Variance inflation factor (VIF) range between 1.25-1.10

 

DISCUSSION

In this study, 3.9% of university students reported having had an STI in the previous 12 months and 21.3% reported receiving STI counseling, testing, or treatment in the same period. EC use was not significantly associated with a higher risk of having an STI. The risk was also insignificant in students who had used EC more than once. STIs were more common among students who had become sexually active before the age of 16, students who had more than 3 sexual partners, students who used condoms inconsistently, and students who used illegal drugs. The use of the oral contraceptive pill, by contrast, was associated with a lower likelihood of STIs. In the adjusted analysis, EC use also exerted a protective effect against STIs.

We have shown that the use of EC on one or more occasions does not increase the likelihood of STIs in university students. Similar results have been reported for women of childbearing age in the United States [2]. This finding is somewhat surprising as EC use and STIs share similar risk factors, such as age at first sexual intercourse, number of sexual partners, and use of illegal drugs [12,20]. In a randomized clinical trial of the impact of access to EC on unintended pregnancies and STIs published for Raine et al. [1], suggested that it did not seem reasonable to restrict EC access to clinical settings, as users who had received EC from more accessible sources did not have significantly higher STI rates. In line with other authors [2,5,21,22], we did not find significantly higher rates of STIs in EC users who had had multiple sexual partners. EC users in university settings may have more access to sexual and reproductive healthcare information and services and, thus, would be more aware than their non-university peers of the risks of STIs and the importance of using protective measures. In this sense, low educational attainment has been described as an important factor for risky sexual behavior and adverse health sexual health outcomes such as STIs in young women and men [23].

As noted in the description of the results, the mean age of the students was 20 (IQR, 17-53 years) and 95% were under 32 years of age. In the adjusted model, having had an STI in the last 12 months was also related to age (OR=0.87, 95%CI 0.79- 0.96). This means that with each additional year of age, there is a lower chance of contracting an STI. We think that this effect could be explained by the fact that age may lead to less sporadic intercourse or to better use of oral contraceptives and condoms on a consistent basis.

Inconsistent condom use has been frequently linked to a greater likelihood of EC use and STI acquisition [24]. Ensuring consistent condom use is key to minimizing STI risk among young people.

We have found a link between STIs and tobacco consumption in accordance with the fact that smoking has been described as a factor associated with more risky sexual behavior [23]. Similarly to Aicken C et al., and Cook RL & Clarck DB [25,26] we found no association between STIs and alcohol use. Other authors, however, have found alcohol to be significantly associated with sexual risk behavior, EC use, and STIs [27]. The lack of association between alcohol use and STIs detected in our study could be due to our methodology, as we distinguished only between “drinkers” and “occasional/non-drinkers”. Similar to other studies, however, we did find that the use of illegal drugs was a risk factor for STIs [27], possibly because the consumption of psychoactive substances may lower inhibitions and cloud judgment when it comes to safe sex. The protective effect observed for oral contraception is consistent with reports that women on the pill are more likely to be in a relationship, have used contraception in the last three sexual encounters, and have had fewer sexual partners [12].

Although healthcare service providers and users have expressed concern that facilitating access to EC might encourage irresponsible sex, possibly leading to an increase in STIs, this association has not been demonstrated. Nonetheless, as reported by several authors, the main reason for using EC is to avoid an unintended pregnancy, with users tending to be less concerned about STIs [18,23,27] and unaware that they are at risk of infection [28]. Considering that EC users share certain risk factors with people who acquire STIs, it is necessary to promote safe sexual behavior in both populations to reduce those risks. Healthcare services and pharmacies should take steps to systematically provide advice on safe sex (particularly in relation to correct and consistent condom use) when dispensing EC. Large-scale implementations of interventions that have been shown to decrease STI risk [29] are necessary to reverse the increasing trend in STI cases.

Limitations and Strengths

As we used a self-administered questionnaire, there is a risk of social desirability bias. Serological testing may have detected a higher rate than the 3.9% detected. Studies in other countries have reported somewhat different STI rates. A nationwide British study, for example, reported a rate of 5.8% for males aged 16-24 years old and of 10.9% for females in the same age category [23], while in Ireland, a rate of 10% was reported for female university students [30]. In Spain, a study performed with Medicine and Law students found a slightly higher rate of STIs (5.9%) [31]. The STI rate according to the proxy question on receipt of STI counseling, testing, and treatment was 21.3%. Another limitation of our study is that we only looked at university students. Our findings, therefore, cannot be extrapolated to segments of the population with more diverse levels of education. Gender stratification would have enhanced the robustness of our study, but would have required an aggregate analysis; however, the low STI rate detected did not endorse this option. In addition, our STI rate could be underestimated because men tend to be unaware of the potential risk of sexual behavior in relation to STIs. Results from other studies show this possible bias with lower rates of STIs in men when compared to women [23].

Our study also has some strength. To minimize the risk of non-response bias, we piloted the questionnaire among a sample of university students to verify that the questions were clear and would not cause offense. We also guaranteed anonymity throughout the data collection and analysis stages, and we strived to create a climate of trust.

CONCLUSIONS

Users of EC on one or more occasions are no more likely than non-users to acquire an STI. We can therefore confirm that EC use in our population of university students does not significantly increase STI risk.

Female sex, sexual activity at an early age, multiple sexual partners, inconsistent condom use, smoking, and illegal drug use were associated with an increased risk of acquiring an STI.

One unexpected finding was that oral contraception use was associated with a lower risk of STI. In the adjusted analysis, older students are at less risk of STIs. EC use also exerted a protective effect against STIs. Our findings suggest that university students may engage in less risky sexual health behaviors than their non-university peers and that there may be a tendency towards overprotection in this setting.

FUNDING

This study was supported by Official College of Nursing of the Balearic Islands–COIBA grant number 586/2014.

AVAILABILITY OF DATA AND MATERIAL

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

AUTHORS’ CONTRIBUTIONS

ML Bauzà conceived the study. MLB, SM and ME participated in the study design. MLB, AE, JM acquired the data. MLB, ME, and SM participated in the analyses and interpretation of the data. MLB, ME drafted the manuscript. MLB, ME, SM JM, AE made critical revisions of the manuscript for key intellectual content, and all authors read and approved the final manuscript.

ETHICS APPROVAL

The study received approval from the Research Ethics Committee of the Balearic Islands (IB-790/14) and from the research committee of the UIB. The study followed the standards of the Declaration of Helsinki.

CONSENT TO PARTICIPATE

As the questionnaire was anonym and voluntary, no informed consent was requested.

REFERENCES

1. Tina R Raine, Cynthia C Harper, Corinne H Rocca, Richard Fischer, Nancy Padian, Jeffrey D Klausner, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: A randomized controlled trial. JAMA. 2005; 293: 54-62.

2. Melissa A Habel, Jami S Leichliter. Emergency contraception and risk for sexually transmitted infections among U.S. women. J Womens Health. 2012; 21: 910–916.

3. Sociedad Española de Contracepción. Encuesta sobre la Anticoncepción en España. Hábitos de la población femenina en relación al uso de los métodos anticonceptivos. 2018.

4. Maria de Lluc Bauzà Amengual, Magdalena Esteva Canto, Inmaculada Pereiro Berenguer, Maria Ingla Pol. Revisión sistemática del perfil de usuarias de anticoncepción de emergencia. Rev. Latino-Am. Enfermagem. 2016; 24.

5. Petra M Sander, Elizabeth G Raymond, Mark A Weaver. Emergency contraceptive use as a marker of future risky sex, pregnancy, and sexually transmitted infection. Am J Obstet Gynecol. 2009; 201: 146. e1-6.

6. ML Bauzà-Amengual, M Esteva, M Ingla-Pol, MA Font-Oliver, S March. (2018). Discourses on the postcoital pill in young women. BMC Public Health. 2018; 18: 803.

7. Hand H. Widening access to contraception: the impact of pharmacy prescribing. Nurse Prescribing. 2010; 8: 58-64.

8. M Bergamini, A Cucchi, E Guidi, A Stefanati, B Bonato, S Lupi. Risk perception of sexually transmitted diseases and teenage sexual behaviour: attitudes towards in a sample of Italian adolescents. J Prev Med Hyg. 2013; 54: 114-119.

9. Sarkar N. Barriers to emergency contraception (EC): does promoting EC increase risk for contacting sexually transmitted infections, HIV/ AIDS? Int J Clin Pract. 2008; 62: 1769–1775.

10. Veronique Verhoeven, Lieve Peremans, Dirk Avonts, Paul Van Royen. The profile of emergency contraception users in a chlamydia prevalence study in primary care in Belgium. Eur J Contracept Reprod Health Care. 2006; 11: 175–80.

11. Nathalie Bajos, Henri Leridon, Hélène Goulard, Pascale Oustry, Nadine Job-Spira, COCON Group. Contraception: from accessibility to efficiency. Hum Reprod. 2003; 18: 994–999.

12. ML Bauzà, M Esteva, J Molina, I Pereiró, M Ingla, S March. Emergency contraception and risk habits in a university population. Eur J Contracept Reprod Health Care. 2018; 23: 427-433.

13. European Centre for Disease Prevention and Control. Sexually transmitted infections in Europe. 2013. 2015.

14. Área de vigilancia del VIH y conductas de riesgo. Vigilancia epidemiológica de las infecciones de transmisión sexual. 2017; 1995- 2015.

15. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance. 2012.

16. García-Vázquez J, Quintó-Domenec L, Nascimento M, Agulló-Tomás E. Evolución de la salud sexual de la población adolescente española y asturiana. Revista Española de Salud Pública. 2019; 93: e201909071.

17. Marianne Johansson Jørgensen, Helle Terkildsen Maindal, Kaj Sparle Christensen, Frede Olesen, Berit Andersen. Sexual behaviour among young Danes aged 15–29 years: a cross-sectional study of core indicators. Sex Transm Infect. 2015; 91: 171–177.

18. Organización Naciones Unidas. Objetivos de desarrollo sostenible. 2015.

19. Rahman M, Berenson AB. Pregnancy Test Taking Is a Correlate of Unsafe Sex, Contraceptive Nonadherence, Pregnancy, and Sexually Transmitted Infections in Adolescent and Young Adult Women. J Womens Health (Larchmt). 2013; 22: 339–343.

20. Sonia Guleria, Christian Munk, K. Miriam Elfström, Bo T. Hansen, Karin Sundström, Kai-Li Liaw, et al. Emergency contraceptive pill use among women in Denmark, Norway and Sweden: Population-based survey. Acta Obstetricia et Gynecologica Scandinavica. 2020; 99: 1214–1221.

21. Durrancia C. The Effects of Increased Access to Emergency Contraception on Sexually Transmitted Disease and Abortion Rates. Economic Inquiry. 2013; 51: 1682–1695.

22. Girma S, Paton D. Matching estimates of the impact of over-thecounter emergency birth control on teenage pregnancy. Health Econ. 2006; 15: 1021–1032.

23. SN Khadr, KG Jones, S Mann, DR Hale, AM Johnson, RM Viner. Investigating the relationship between substance use and sexual in young people in Britain: findings from a national probability survey. BMJ Open. 2016; 6.

24. Borges AL, Fujimori E, Komura L, Vieira M. Contraceptive practices among university students: the use of emergency contraception. Cad Public Health. 2010; 26: 816–826.

25. Catherine RH Aicken, Anthony Nardone, Catherine H Mercer. Alcohol misuse, sexual risk behaviour and adverse sexual health outcomes: evidence from Britain’s national probability sexual behaviour surveys. J Public Health (Oxf). 2011; 33: 262–271.

26. Cook RL, Clark DB. Is There an Association Between Alcohol Consumption and Sexually Transmitted Diseases? A Systematic Review. Sex Transm Dis. 2005; 32: 156–164.

27. Justine Wu, Teresa Gipson, Nancy Chin, LL Wynn, Kelly Cleland, Coleen Morrison, et al. Women Seeking Emergency Contraceptive Pills by Using the Internet. Obstet Gynecol. 2007; 110: 44-52.

28. Mary T Hickey, Michele G Shedlin. Emergency contraceptive pill users’ risk perceptions for sexually transmitted infections and future unintended pregnancy. J Am Assoc Nurse Pract. 2017; 29: 527–534.

29. Dafina Petrova, Rocio Garcia-Retamero. Effective Evidence-Based Programs For Preventing Sexually-Transmitted Infections: A MetaAnalysis. Curr HIV Res. 2015; 13: 432–438.

30. K Lally, Y Nathan-V, S Dunne, D McGrath, W Cullen, D Meagher, et al. Awareness of sexually transmitted infection and protection methods among university students in Ireland. Ir J Med Sci. 2015; 184: 135-42.

31. Pluvio J Coronado, Carlos Delgado-Miguel, Adriana Rey-Cañas, Miguel A Herráiz. Sexual and reproductive health in Spanish University Students. A comparison between medical and law students. Sex Reprod Healthc. 2017; 11: 97–101.

de Lluc Bauzà-Amengual M, March S, Esteva A, Miralles-Xamena J, Esteva M (2022) Sexually Transmitted Infections and Emergency Contraception in University Students in Majorca, Spain. JSM Sexual Med 6(2): 1086.

Received : 25 Apr 2022
Accepted : 20 Jun 2022
Published : 22 Jun 2022
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X